Impaired β-adrenoceptor mediated venodilation in patients with diabetes mellitus

被引:8
作者
Harada, K [1 ]
Ohmori, M [1 ]
Kitoh, Y [1 ]
Sugimoto, K [1 ]
Fujimura, A [1 ]
机构
[1] Jichi Med Sch, Dept Clin Pharmacol, Minami Kawachi, Tochigi 3290498, Japan
关键词
diabetes mellitus; vein; vascular response; alpha- and beta-adrenoceptors; nitroglycerin;
D O I
10.1046/j.1365-2125.1999.00915.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims We investigated whether venoconstriction by alpha-adrenoceptor stimulation, and venodilation by beta-adrenoceptor stimulation and nitroglycerin are altered in patients with diabetes mellitus (DM). Methods Eight male patients with non insulin-dependent DM and eight age-matched control subjects were included. The patients had neither hypertension nor hyperlipidaemia. Noradrenaline (1 to 512 ng min(-1)), isoprenaline (1 to 256 ng min(-1)) and nitroglycerin (0.5 to 128 ng min(-1)) were infused into a dorsal hand vein and its diameter was measured using a linear variable differential transformer. Results The venoconstricting response to noradrenaline and the venodilating response to nitroglycerin in DM patients were similar to those in control subjects, while the venodilation by isoprenaline was significantly (P<0.05) smaller in DM patients than in control subjects at the dose of 32 ng min(-1) or more [32 ng min(-1) 11.5% vs 29.8% (DM vs control subjects), 64 ng min(-1) 19.0% vs 40.1%, 128 ng min(-1) 25.2% vs 49.0%, 256 ng min(-1): 34.3% vs 56.7%]. Conclusions These data suggested that venoconstriction by alpha-adrenoceptor stimulation and venodilation by nitroglycerin are not altered, whereas venodilation by beta-adrenoceptor stimulation might be impaired in patients with DM.
引用
收藏
页码:427 / 431
页数:5
相关论文
共 23 条
  • [1] A NEW TECHNIQUE FOR RECORDING COMPLIANCE OF HUMAN HAND VEINS
    AELLIG, WH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (03) : 237 - 243
  • [2] ARTERIOSCLEROSIS OBLITERANS AND ASSOCIATED RISK-FACTORS IN INSULIN-DEPENDENT AND NON-INSULIN-DEPENDENT DIABETES
    BEACH, KW
    STRANDNESS, DE
    [J]. DIABETES, 1980, 29 (11) : 882 - 888
  • [3] Decreased vasodilator response to isoproterenol during nitric oxide inhibition in humans
    Cardillo, C
    Kilcoyne, CM
    Quyyumi, AA
    Cannon, RO
    Panza, JA
    [J]. HYPERTENSION, 1997, 30 (04) : 918 - 921
  • [4] VASCULAR REACTIVITY TO ANGIOTENSIN -2 AND TO NOREPINEPHRINE IN DIABETIC SUBJECTS
    CHRISTLIEB, AR
    JANKA, HU
    KRAUS, B
    GLEASON, RE
    ICASASCABRAL, EA
    AIELLO, LM
    CABRAL, BV
    SOLANO, A
    [J]. DIABETES, 1976, 25 (04) : 268 - 274
  • [5] RESPONSIVENESS OF SUPERFICIAL HAND VEINS TO ALPHA-ADRENOCEPTOR AGONISTS IN INSULIN-DEPENDENT DIABETIC-PATIENTS
    EICHLER, HG
    BLASCHKE, TF
    KRAEMER, FB
    FORD, GA
    BLOCHLDAUM, B
    HOFFMAN, BB
    [J]. CLINICAL SCIENCE, 1992, 82 (02) : 163 - 168
  • [6] ABSENCE OF AGE-RELATED-CHANGES IN VENOUS RESPONSIVENESS TO NITROGLYCERIN INVIVO IN HUMANS
    EICHLER, HG
    HIREMATH, A
    KATZIR, D
    BLASCHKE, TF
    HOFFMAN, BB
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (05) : 521 - 524
  • [7] FOSSET M, 1988, J BIOL CHEM, V263, P7933
  • [8] NOVEL SIGNAL TRANSDUCTION PATHWAY MEDIATING ENDOTHELIUM-DEPENDENT BETA-ADRENOCEPTOR VASORELAXATION IN RAT THORACIC AORTA
    GRAY, DW
    MARSHALL, I
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (03) : 684 - 690
  • [9] Influence of age on venodilator effect of isoproterenol and amrinone
    Harada, K
    Ohashi, K
    Kumagai, Y
    Ohmori, M
    Fujimura, A
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 50 (1-2) : 37 - 40
  • [10] Hiraga K., 1992, CLIN REPORT, V26, P283